Design Therapeutics Inc. (DSGN)

Design Therapeutics Inc. (DSGN $3.93)
- $3.93 Cap: $236M
- View DSGN Profile
- View Questions on DSGN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Enghouse Systems Limited (ENGH $23.40)
- $23.40 Fwd P/E: 16.31X Cap: $1.29B
- View ENGH Profile
- View Questions on ENGH
- View Reports on ENGH
Nuvei Corporation Subordinate Voting Shares (NVEI $47.61)
- $47.61 Cap: $6.75B
- View NVEI Profile
- View Questions on NVEI
Design Therapeutics Inc. (DSGN $3.93)
- $3.93 Cap: $236M
- View DSGN Profile
- View Questions on DSGN

Q: Would you endorse a switch from ENGH to NVEI for more long term growth? Or is there another stock(s) that would have more growth than ENGH, if so, could you list it?

Thanks for your service!

Read Answer Asked by Ozzie on February 21, 2023